These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27377469)

  • 21. Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis.
    Rueda B; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2008 May; 35(5):850-4. PubMed ID: 18381780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cluster of Differentiation 24 Polymorphism Has No Significant Association with Chronic Hepatitis B Virus Infection in the Chinese Han Population: A Family-Based Association Study.
    Xia S; Ding J; Zhang Z; Li X; Gan J; He X
    Infect Drug Resist; 2022; 15():4837-4843. PubMed ID: 36043159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
    Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD24 single nucleotide polymorphisms and cancer risk.
    Yan S; Xu D; Jiang T; Wang P; Yin Y; Wang X; Hua C; Zhang B; Li Z; Lu L; Liu X; Wang B; Zhang D; Zhang R; Sun B; Wang X
    Tumour Biol; 2014 Sep; 35(9):8927-32. PubMed ID: 24894672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer risk alleles are associated with prostate cancer volume and prostate size.
    Reinhardt D; Helfand BT; Cooper PR; Roehl KA; Catalona WJ; Loeb S
    J Urol; 2014 Jun; 191(6):1733-6. PubMed ID: 24345439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease.
    Ribeiro R; Vasconcelos A; Costa S; Pinto D; Morais A; Oliveira J; Lobo F; Lopes C; Medeiros R
    Prostate; 2004 May; 59(3):268-74. PubMed ID: 15042602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A polymorphism in the CYP17 gene is associated with prostate cancer risk.
    Gsur A; Bernhofer G; Hinteregger S; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
    Int J Cancer; 2000 Aug; 87(3):434-7. PubMed ID: 10897051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection.
    Nam RK; Zhang WW; Trachtenberg J; Diamandis E; Toi A; Emami M; Ho M; Sweet J; Evans A; Jewett MA; Narod SA
    J Clin Oncol; 2003 Jun; 21(12):2312-9. PubMed ID: 12805332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
    Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.
    Narita S; Tsuchiya N; Wang L; Matsuura S; Ohyama C; Satoh S; Sato K; Ogawa O; Habuchi T; Kato T
    Int J Cancer; 2004 Dec; 112(5):872-6. PubMed ID: 15386377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
    Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
    Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD24 as a genetic modifier of disease progression in multiple sclerosis in Argentinean patients.
    González SJ; Rojas JI; Redal MA; Patrucco L; Correale J; Argibay PF; Cristiano E
    J Neurol Sci; 2011 Aug; 307(1-2):18-21. PubMed ID: 21641619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness.
    Cicek MS; Liu X; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2173-7. PubMed ID: 16172228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
    Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
    Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of caspases with an increased prostate cancer risk in north Indian population.
    Mittal RD; Mittal T; Singh AK; Mandal RK
    DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
    Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
    DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy.
    Zhang X; Hu Q; Chen Y; Li M; Yin H; Zhou C; Li G; Hou J
    Technol Cancer Res Treat; 2017 Dec; 16(6):1168-1172. PubMed ID: 29332451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
    Paz-y-Miño C; Witte T; Robles P; Llumipanta W; Díaz M; Arévalo M
    Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis.
    Zhang CC; Voitl R; Hippchen T; Weiss KH; Sauer P; Rupp C
    Scand J Gastroenterol; 2020 May; 55(5):581-587. PubMed ID: 32329406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.